Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.
Neuroendocrine tumours (NETs) represent a heterogeneous family of neoplasms, which may develop from different endocrine glands (such as the pituitary, the parathyroid or the neuroendocrine adrenal glands), endocrine islets (within the thyroid or pancreas) as well as from endocrine cells dispersed be...
Những tác giả chính: | Grozinsky-Glasberg, S, Shimon, I, Korbonits, M, Grossman, AB |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2008
|
Những quyển sách tương tự
-
The role of somatostatin analogues in the treatment of neuroendocrine tumours.
Bằng: Grozinsky-Glasberg, S, et al.
Được phát hành: (2008) -
Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
Bằng: Kaltsas, G, et al.
Được phát hành: (2005) -
Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: a comparative study.
Bằng: King, C, et al.
Được phát hành: (1993) -
Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
Bằng: Gupta, P, et al.
Được phát hành: (2014) -
Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
Bằng: Ur, E, et al.
Được phát hành: (1993)